The latest news, developments and research findings from all fields of science including biology, chemistry, physics, psychology, sociology and space, including news on the latest policies regulating this sector.
Katri Huitu and Kati Lassila-Perini from Helsinki Institute of Physics, Finland, chart open science in the making including a short overview of related accelerator research expertise in Finland.
Megan Warrender, Assistant Editor at Open Access Government, discusses research and innovation in Europe, and why in a post COVID-19 world, science is more important than ever.
Benjamin S. Hsiao, Distinguished Professor from Stony Brook University details nanocellulose filters for water purification in this fascinating chemistry focus.
Alberto Mantovani from Istituto Superiore di Sanità, Roma, Italy, looks at an aspect of food safety that concerns assessing mixtures of endocrine disruptors.
Frédérique Vidal, Minister of Higher Education, Research, and Innovation in France, weighs up the benefits and challenges of achieving open science in Europe.
Professor Sandra Carvalho, University of Minho, Department of Physics, discusses the emergence of surface functionalization as a strategy in biotech and health.
Here, Open Access Government probes how the National Science Foundation in the U.S. supports extending intellectual frontiers in the atmospheric and geospace sciences.
Cristiano Malossi, PhD, Manager AI Automation at IBM Research – Zurich tells us what we need to know about the OPRECOMP project that concerns transprecision computing for energy efficiency.
Dr David Carroll from CU Aerospace LLC says that there are advantages to nano-satellites and the Space 2.0 environment, but they exacerbate the problem of orbital debris.
Chairman for the global initiative EU Joint Programme – Neurodegenerative Disease Research (JPND) Professor Philippe Amouyel brings to light their innovative work in neurodegenerative disease research.
Jean Van Rampelbergh PhD, VP Clinical & Regulatory at Imcyse SA, introduces Imotopes™, the innovative new immunotherapy approach causing scientists to rethink Type 1 diabetes and its treatment.
